Page last updated: 2024-10-22

amodiaquine and Fatty Liver

amodiaquine has been researched along with Fatty Liver in 1 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, HY1
Kim, B1
Ryu, HG1
Ji, Y1
Park, S1
Choi, SH1
Lee, D1
Lee, IK1
Kim, M1
Lee, YJ1
Song, W1
Lee, YH1
Choi, HJ1
Hyun, CK1
Holzapfel, WH1
Kim, KT1

Other Studies

1 other study available for amodiaquine and Fatty Liver

ArticleYear
Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice.
    Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:7

    Topics: 3T3-L1 Cells; Amodiaquine; Animals; Antimalarials; Blood Glucose; Body Weight; Cell Proliferation; D

2018